Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 2,076 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q2
EFB ADVOCACY, LLC for ASSOCIATION OF AMERICAN CANCER INSTITUTES
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $22,500.00 income
Medical/Disease Research/Clinical Labs, Budget/Appropriations, Health Issues
View →
Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for THE UNIVERSITY OF TEXAS AT SAN ANTONIO
2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate · $50,000.00 income
Defense, Education, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q2
BALLARD PARTNERS for ERUDIO BIO, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · $50,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q2
BALLARD PARTNERS for BIOSTAR MEDICAL LLC
2nd Quarter (Apr 1 - June 30) 2026 · Texas · $300,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q2
CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Budget/Appropriations, Science/Technology, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
Q2
SQUIRE PATTON BOGGS for ALLIANCE FOR BIOSECURITY
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $40,000.00 income
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
ADAMS AND REESE, LLP for ORCA BIO
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $20,000.00 income
Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q2
MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) for OSTEAL THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate · $40,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q2
IMPACT MANAGEMENT GROUP for ARKANSAS RESEARCH ALLIANCE
2nd Quarter (Apr 1 - June 30) 2026 · Arkansas · House · Senate
Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q2
IMPACT MANAGEMENT GROUP for CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Arkansas · House
Medical/Disease Research/Clinical Labs, Health Issues
View →
Q2
BALLARD PARTNERS for 23ANDME RESEARCH INSTITUTE
2nd Quarter (Apr 1 - June 30) 2026 · California · $10,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q2
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY for AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Labor Issues/Antitrust/Workplace, Medicare/Medicaid
View →
Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for CITY OF HOPE MEDICAL CENTER
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $50,000.00 income
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for CHILDREN'S NATIONAL MEDICAL CENTER
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for THE UNITED STATES PHARMACOPEIAL CONVENTION
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $60,000.00 income
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Trade (domestic/foreign)
View →
Q2
FOOD ALLERGY RESEARCH AND EDUCATION (FARE) for FOOD ALLERGY RESEARCH AND EDUCATION (FARE)
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Medical/Disease Research/Clinical Labs, Food Industry (safety, labeling, etc.), Health Issues
View →
Q2
NELSON MULLINS RILEY & SCARBOROUGH for ANBEX, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $15,000.00 income
Medical/Disease Research/Clinical Labs, Energy/Nuclear
View →
RR
ALPINE GROUP PARTNERS, LLC. for PHRMA
1st Quarter (Jan 1 - Mar 31) 2026 · California
Health Issues, Government Issues, Medical/Disease Research/Clinical Labs, Pharmacy
View →
RR
ALPINE GROUP PARTNERS, LLC. for ULTRAGENYX PHARMACEUTICAL INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California
Health Issues, Government Issues, Medical/Disease Research/Clinical Labs
View →
Q2
AMERICAN PHYSICAL THERAPY ASSOCIATION for AMERICAN PHYSICAL THERAPY ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Budget/Appropriations, Education, Health Issues, Medicare/Medicaid
View →
Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for CASE WESTERN RESERVE UNIVERSITY
2nd Quarter (Apr 1 - June 30) 2026 · Ohio · House · Senate · $80,000.00 income
Education, Defense, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for OCTAPHARMA USA, INC.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · Senate · $90,000.00 income
Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Manufacturing
View →
Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for MEDIVIEW XR, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Ohio · $40,000.00 income
Defense, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for WASHINGTON STATE UNIVERSITY
2nd Quarter (Apr 1 - June 30) 2026 · Washington · House · Senate · $50,000.00 income
Defense, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for TELEFLEX INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · $20,000.00 income
Defense, Medical/Disease Research/Clinical Labs
View →
Previous Page 12 of 84 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem